Dr. Rizzo discusses how the 31-GEP test can inform routine imaging guidance and provides improved risk stratification in patients with melanoma.
References:
- Dhillon S, Duarte-Bateman D, Fowler G, et al. Routine imaging guided by a 31-gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies. Arch Dermatol Res. 2023;315(8):2295-2302.
- Durgham RA, Nassar SI, Gun R, et al. The prognostic value of the 31-gene expression profile test in cutaneous melanoma: a systematic review and meta-analysis. Cancers (Basel). 2024;16(21):3714.
